Clinical Trial Update: Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of a PIKA-adjuvanted rabies vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• PIKA Rabies Vaccine (PIKA adjuvant) (PIKA-adjuvanted rabies vaccine)

Snippet

Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd. | Conditions: Rabies | Phase 1 | Status: COMPLETED